These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36747619)

  • 21. Frequency of pathogenic germline variants in pediatric medulloblastoma survivors.
    Rees D; Gianferante DM; Kim J; Stavrou T; Reaman G; Sapkota Y; Gramatges MM; Morton LM; Hudson MM; Armstrong GT; Freedman ND; Huang WY; Diver WR; Lori A; Luo W; Hicks BD; Liu J; Hutchinson AA; Goldstein AM; Mirabello L
    Front Oncol; 2024; 14():1441958. PubMed ID: 39184053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Susceptibility study on the germline rare variants of bromodomain and extraterminal domain protein family-encoding genes and patients with cancer living in some regions of China].
    Huang Y; Li JH; Wang X; Zou Y; Huang WF; Liu C; Zhang H
    Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(42):3374-3381. PubMed ID: 36372767
    [No Abstract]   [Full Text] [Related]  

  • 23. The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility.
    Liu M; Liu X; Suo P; Gong Y; Qu B; Peng X; Xiao W; Li Y; Chen Y; Zeng Z; Lu Y; Huang T; Zhao Y; Liu M; Li L; Chen Y; Zhou Y; Liu G; Yao J; Chen S; Song L
    Transl Lung Cancer Res; 2020 Jun; 9(3):646-658. PubMed ID: 32676327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
    Zhong X; Dong Z; Dong H; Li J; Peng Z; Deng L; Zhu X; Sun Y; Lu X; Shen F; Su X; Zhang L; Gu Y; Zheng H
    PLoS One; 2016; 11(6):e0156789. PubMed ID: 27257965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline functional variants contribute to somatic mutation and outcomes in neuroblastoma.
    Seo ES; Lee JW; Lim J; Shin S; Cho HW; Ju HY; Yoo KH; Sung KW; Park WY
    Nat Commun; 2024 Sep; 15(1):8360. PubMed ID: 39333105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management.
    McGee RB; Oak N; Harrison L; Xu K; Nuccio R; Blake AK; Mostafavi R; Lewis S; Taylor LM; Kubal M; Ouma A; Hines-Dowell SJ; Cheng C; Furtado LV; Nichols KE
    Clin Cancer Res; 2023 Apr; 29(7):1243-1251. PubMed ID: 36693186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features.
    Nguyen CB; Knaus C; Li J; Accardo ML; Koeppe E; Vaishampayan UN; Alva AS; Else T
    JCO Precis Oncol; 2023 Sep; 7():e2300168. PubMed ID: 38127826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma.
    Nassar AH; Abou Alaiwi S; AlDubayan SH; Moore N; Mouw KW; Kwiatkowski DJ; Choueiri TK; Curran C; Berchuck JE; Harshman LC; Nuzzo PV; Chanza NM; Van Allen E; Esplin ED; Yang S; Callis T; Garber JE; Rana HQ; Sonpavde G
    Genet Med; 2020 Apr; 22(4):709-718. PubMed ID: 31844177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of pathogenic/likely pathogenic germline variants in cancer-related genes among children with acute leukemia in Saudi Arabia.
    Alsultan A; Essa M; Aljefri A; Ayas M; Alharbi M; Alkhayat N; Al-Anzi F; Yassin F; Alkasim F; Alharbi Q; Abdullah S; Jastaniah W
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28340. PubMed ID: 32359129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes.
    Mossanen M; Nassar AH; Stokes SM; Martinez-Chanza N; Kumar V; Nuzzo PV; Kwiatkowski DJ; Garber JE; Curran C; Freeman D; Preston M; Mouw KW; Kibel A; Choueiri TK; Sonpavde G; Rana HQ
    Clin Genitourin Cancer; 2022 Dec; 20(6):568-574. PubMed ID: 36127252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
    Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
    Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
    Yurgelun MB; Chittenden AB; Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Qian ZR; Welch MW; Brais LK; Da Silva A; Bui JL; Yuan C; Li T; Li W; Masuda A; Gu M; Bullock AJ; Chang DT; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Thorner AR; Ducar MD; Wollison BM; Khalaf N; Perez K; Syngal S; Aguirre AJ; Hahn WC; Meyerson ML; Fuchs CS; Ogino S; Hornick JL; Hezel AF; Koong AC; Nowak JA; Wolpin BM
    Genet Med; 2019 Jan; 21(1):213-223. PubMed ID: 29961768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.
    Carlo MI; Ravichandran V; Srinavasan P; Bandlamudi C; Kemel Y; Ceyhan-Birsoy O; Mukherjee S; Mandelker D; Chaim J; Knezevic A; Rana S; Fnu Z; Breen K; Arnold AG; Khurram A; Tkachuk K; Cipolla CK; Regazzi A; Hakimi AA; Al-Ahmadie H; Dalbagni G; Cadoo KA; Walsh MF; Teo MY; Funt SA; Coleman JA; Bochner BH; Iyer G; Solit DB; Stadler ZK; Zhang L; Rosenberg JE; Taylor BS; Robson ME; Berger MF; Vijai J; Bajorin DF; Offit K
    J Clin Oncol; 2020 Feb; 38(5):406-414. PubMed ID: 31794323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
    Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA
    BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients.
    Yang J; Li H; Li B; Li W; Guo Q; Hu L; Song Z; Zhou B
    Front Oncol; 2021; 11():647598. PubMed ID: 33898318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations.
    Yehia L; Seyfi M; Niestroj LM; Padmanabhan R; Ni Y; Frazier TW; Lal D; Eng C
    JAMA Netw Open; 2020 Jan; 3(1):e1920415. PubMed ID: 32003824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
    Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
    Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.
    AlDubayan SH; Pyle LC; Gamulin M; Kulis T; Moore ND; Taylor-Weiner A; Hamid AA; Reardon B; Wubbenhorst B; Godse R; Vaughn DJ; Jacobs LA; Meien S; Grgic M; Kastelan Z; Markt SC; Damrauer SM; Rader DJ; Kember RL; Loud JT; Kanetsky PA; Greene MH; Sweeney CJ; Kubisch C; Nathanson KL; Van Allen EM; Stewart DR; Lessel D;
    JAMA Oncol; 2019 Apr; 5(4):514-522. PubMed ID: 30676620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
    Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
    Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.